| Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA) H Ratni, M Ebeling, J Baird, S Bendels, J Bylund, KS Chen, N Denk, ... Journal of Medicinal Chemistry 61 (15), 6501-6517, 2018 | 480 | 2018 |
| Chemically advanced template search (CATS) for scaffold-hopping and prospective target prediction for ‘orphan’molecules M Reutlinger, CP Koch, D Reker, N Todoroff, P Schneider, T Rodrigues, ... Molecular informatics 32 (2), 133, 2013 | 158 | 2013 |
| Revealing the macromolecular targets of complex natural products D Reker, AM Perna, T Rodrigues, P Schneider, M Reutlinger, B Mönch, ... Nature chemistry 6 (12), 1072-1078, 2014 | 133 | 2014 |
| Rationalizing tight ligand binding through cooperative interaction networks B Kuhn, JE Fuchs, M Reutlinger, M Stahl, NR Taylor Journal of chemical information and modeling 51 (12), 3180-3198, 2011 | 108 | 2011 |
| Voyages to the (un) known: adaptive design of bioactive compounds G Schneider, M Hartenfeller, M Reutlinger, Y Tanrikulu, E Proschak, ... Trends in biotechnology 27 (1), 18-26, 2009 | 100 | 2009 |
| Multi‐objective molecular de novo design by adaptive fragment prioritization M Reutlinger, T Rodrigues, P Schneider, G Schneider Angewandte Chemie International Edition 53 (16), 4244-4248, 2014 | 97 | 2014 |
| Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery M Reutlinger, G Schneider Journal of Molecular Graphics and Modelling 34, 108-117, 2012 | 81 | 2012 |
| Combining on‐chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands M Reutlinger, T Rodrigues, P Schneider, G Schneider Angewandte Chemie International Edition 53 (2), 582-585, 2014 | 80 | 2014 |
| Immunosuppressive Small Molecule Discovered by Structure‐Based Virtual Screening for Inhibitors of Protein–Protein Interactions T Geppert, S Bauer, JA Hiss, E Conrad, M Reutlinger, P Schneider, ... Angewandte Chemie International Edition 1 (51), 258-261, 2011 | 48 | 2011 |
| Discovery of a novel class of survival motor neuron 2 splicing modifiers for the treatment of spinal muscular atrophy E Pinard, L Green, M Reutlinger, M Weetall, NA Naryshkin, J Baird, ... Journal of medicinal chemistry 60 (10), 4444-4457, 2017 | 47 | 2017 |
| Multidimensional De Novo Design Reveals 5‐HT2B Receptor‐Selective Ligands T Rodrigues, N Hauser, D Reker, M Reutlinger, T Wunderlin, J Hamon, ... Angewandte Chemie International Edition 54 (5), 1551-1555, 2015 | 47 | 2015 |
| Reaction-Driven De Novo Design, Synthesis and Testing of Potential Type II Kinase Inhibitors G Schneider, T Geppert, M Hartenfeller, F Reisen, A Klenner, ... Future medicinal chemistry 3 (4), 415-424, 2011 | 47 | 2011 |
| Neighborhood‐Preserving Visualization of Adaptive Structure–Activity Landscapes: Application to Drug Discovery M Reutlinger, W Guba, RE Martin, AI Alanine, T Hoffmann, A Klenner, ... Angewandte Chemie International Edition 49 (50), 11633-11636, 2011 | 45 | 2011 |
| Machine learning estimates of natural product conformational energies M Rupp, MR Bauer, R Wilcken, A Lange, M Reutlinger, FM Boeckler, ... PLoS computational biology 10 (1), e1003400, 2014 | 44 | 2014 |
| Drugs by numbers: reaction‐driven de novo design of potent and selective anticancer leads B Spänkuch, S Keppner, L Lange, T Rodrigues, H Zettl, CP Koch, ... Angewandte Chemie International Edition 52 (17), 4676-4681, 2013 | 31 | 2013 |
| Understanding molecular drivers of melanin binding to support rational design of small molecule ophthalmic drugs P Jakubiak, M Reutlinger, P Mattei, F Schuler, A Urtti, R Alvarez-Sánchez Journal of medicinal chemistry 61 (22), 10106-10115, 2018 | 30 | 2018 |
| A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios A Tosstorff, MG Rudolph, JC Cole, M Reutlinger, C Kramer, ... Journal of Computer-Aided Molecular Design 36 (10), 753-765, 2022 | 21 | 2022 |
| Exhaustive proteome mining for functional MHC-I ligands CP Koch, AM Perna, S Weissmüller, S Bauer, M Pillong, RB Baleeiro, ... ACS chemical biology 8 (9), 1876-1881, 2013 | 19 | 2013 |
| Combinatorial chemistry by ant colony optimization JA Hiss, M Reutlinger, CP Koch, AM Perna, P Schneider, T Rodrigues, ... Future medicinal chemistry 6 (3), 267-280, 2014 | 18 | 2014 |
| Discovery of RO7185876, a highly potent γ-secretase modulator (GSM) as a potential treatment for Alzheimer’s disease H Ratni, A Alker, B Bartels, C Bissantz, W Chen, I Gerlach, A Limberg, ... ACS Medicinal Chemistry Letters 11 (6), 1257-1268, 2020 | 17 | 2020 |
Dr. Jan A. HissETH Zürich在 gmx.org 的电子邮件经过验证
